Global Citizen Capital and two of its portfolio companies: Forall Biotech and MitoBioMed have officially joined #China and its national #coronavirus initiative.
First work stream: utilize molecular medicine research to prevent the virus from replication
Second work stream: mobilize proven cellular rejuvenation technology to boost immunity of infected patients